Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia

ObjectiveThe aim of this study was to fully describe the clinical and genetic characteristics, including clinical manifestations, intact fibroblast growth factor 23 (iFGF23) levels, and presence of PHEX gene mutations, of 22 and 7 patients with familial and sporadic X-linked dominant hypophosphatemi...

Full description

Bibliographic Details
Main Authors: Tian Xu, Xiaohui Tao, Zhenlin Zhang, Hua Yue
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.956646/full
_version_ 1818483730660982784
author Tian Xu
Xiaohui Tao
Zhenlin Zhang
Hua Yue
author_facet Tian Xu
Xiaohui Tao
Zhenlin Zhang
Hua Yue
author_sort Tian Xu
collection DOAJ
description ObjectiveThe aim of this study was to fully describe the clinical and genetic characteristics, including clinical manifestations, intact fibroblast growth factor 23 (iFGF23) levels, and presence of PHEX gene mutations, of 22 and 7 patients with familial and sporadic X-linked dominant hypophosphatemia (XLH), respectively.MethodsDemographic data, clinical features, biochemical indicators, and imaging data of 29 patients were collected. All 22 exons and exon–intron boundaries of the PHEX gene were amplified by polymerase chain reaction (PCR) and directly sequenced. The serum level of iFGF23 was measured in 15 of the patients.ResultsTwenty-nine patients (male/female: 13:16, juvenile/adult: 15:14) with XLH were included. The main symptoms were bowed lower extremities (89.7%), abnormal gait (89.7%), and short stature/growth retardation (78.6%). Hypophosphatemia with a high alkaline phosphatase level was the main biochemical feature and the median value of serum iFGF23 was 55.7 pg/ml (reference range: 16.1–42.2 pg/ml). Eight novel mutations in the PHEX gene were identified by Sanger sequencing, including two missense mutations (p. Gln682Leu and p. Phe312Ser), two deletions (c.350_356del and c.755_761del), one insertion (c.1985_1986insTGAC), and three splice mutations (c.1700+5G>C, c.1966-1G>T, and c.350-14_350-1del). Additionally, the recurrence rate after the first orthopedic surgery was 77.8% (7/9), and five of them had their first surgery before puberty.ConclusionOur study expanded the clinical phenotypes and gene mutation spectrum of XLH and provided a reference for the optimal timing of orthopedic surgeries.
first_indexed 2024-12-10T15:45:48Z
format Article
id doaj.art-75a2ed7300914b2ea7375539d3df0708
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-10T15:45:48Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-75a2ed7300914b2ea7375539d3df07082022-12-22T01:42:57ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-08-011310.3389/fendo.2022.956646956646Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemiaTian XuXiaohui TaoZhenlin ZhangHua YueObjectiveThe aim of this study was to fully describe the clinical and genetic characteristics, including clinical manifestations, intact fibroblast growth factor 23 (iFGF23) levels, and presence of PHEX gene mutations, of 22 and 7 patients with familial and sporadic X-linked dominant hypophosphatemia (XLH), respectively.MethodsDemographic data, clinical features, biochemical indicators, and imaging data of 29 patients were collected. All 22 exons and exon–intron boundaries of the PHEX gene were amplified by polymerase chain reaction (PCR) and directly sequenced. The serum level of iFGF23 was measured in 15 of the patients.ResultsTwenty-nine patients (male/female: 13:16, juvenile/adult: 15:14) with XLH were included. The main symptoms were bowed lower extremities (89.7%), abnormal gait (89.7%), and short stature/growth retardation (78.6%). Hypophosphatemia with a high alkaline phosphatase level was the main biochemical feature and the median value of serum iFGF23 was 55.7 pg/ml (reference range: 16.1–42.2 pg/ml). Eight novel mutations in the PHEX gene were identified by Sanger sequencing, including two missense mutations (p. Gln682Leu and p. Phe312Ser), two deletions (c.350_356del and c.755_761del), one insertion (c.1985_1986insTGAC), and three splice mutations (c.1700+5G>C, c.1966-1G>T, and c.350-14_350-1del). Additionally, the recurrence rate after the first orthopedic surgery was 77.8% (7/9), and five of them had their first surgery before puberty.ConclusionOur study expanded the clinical phenotypes and gene mutation spectrum of XLH and provided a reference for the optimal timing of orthopedic surgeries.https://www.frontiersin.org/articles/10.3389/fendo.2022.956646/fullX-linked dominant hypophosphatemiaPHEXfibroblast growth factor 23clinical featuresgene mutation
spellingShingle Tian Xu
Xiaohui Tao
Zhenlin Zhang
Hua Yue
Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
Frontiers in Endocrinology
X-linked dominant hypophosphatemia
PHEX
fibroblast growth factor 23
clinical features
gene mutation
title Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
title_full Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
title_fullStr Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
title_full_unstemmed Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
title_short Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
title_sort clinical and genetic characteristics of 29 chinese patients with x linked hypophosphatemia
topic X-linked dominant hypophosphatemia
PHEX
fibroblast growth factor 23
clinical features
gene mutation
url https://www.frontiersin.org/articles/10.3389/fendo.2022.956646/full
work_keys_str_mv AT tianxu clinicalandgeneticcharacteristicsof29chinesepatientswithxlinkedhypophosphatemia
AT xiaohuitao clinicalandgeneticcharacteristicsof29chinesepatientswithxlinkedhypophosphatemia
AT zhenlinzhang clinicalandgeneticcharacteristicsof29chinesepatientswithxlinkedhypophosphatemia
AT huayue clinicalandgeneticcharacteristicsof29chinesepatientswithxlinkedhypophosphatemia